Description

Tesamorelin / Ipamorelin Blend – 5mg / 5mg Capsules

The Tesamorelin/Ipamorelin blend combines two powerful synthetic peptides that work synergistically to stimulate growth hormone (GH) secretion. Tesamorelin is a GHRH analog that boosts GH production naturally, while Ipamorelin is a ghrelin mimetic that selectively triggers GH release without significantly affecting cortisol or prolactin levels. Together, they offer a dual-pathway approach for metabolic, fat loss, and muscle growth research.

Mechanism of Action

• Dual GH Stimulation: Tesamorelin activates GHRH receptors in the pituitary, enhancing GH pulsatility. Ipamorelin stimulates the ghrelin receptor, providing additional GH release.

• Metabolic Support: The blend promotes fat metabolism, increases lean muscle mass, and improves insulin sensitivity.

• Visceral Fat Reduction: Studies suggest that enhanced GH secretion may reduce visceral adipose tissue, which is linked to metabolic disorders.

• Controlled GH Release: Ipamorelin’s selective action minimizes unwanted hormonal effects, making this blend ideal for body composition and metabolic studies.

Research Applications

• Investigating fat loss and body composition

• Studying muscle growth, protein synthesis, and recovery

• Exploring GH pathway interactions in metabolic and endocrine research

• Assessing effects on visceral fat reduction and insulin sensitivity

Why Researchers Use This Blend

The Tesamorelin/Ipamorelin combination provides a synergistic, dual-mechanism approach to GH modulation. It offers enhanced efficacy over single-peptide therapies, supporting advanced research in metabolic health, tissue repair, and age-related GH deficiency. Current studies highlight its potential to improve fat metabolism, muscle hypertrophy, and metabolic function, while remaining a controlled and safe research peptide.

For Research Use Only
Not for human consumption. Strictly intended for laboratory and scientific research purposes.